Complement component 5: Difference between revisions

Revision as of 02:01, 4 December 2017

Revision as of 10:08, 16 April 2020

Line 41:

*{{cite journal | vauthors=Zuiderweg ER, Mollison KW, Henkin J, Carter GW |title=Sequence-specific assignments in the 1H NMR spectrum of the human inflammatory protein C5a |journal=Biochemistry |volume=27 |issue= 10 |pages= 3568–80 |year= 1988 |pmid= 3408713 |doi=10.1021/bi00410a007 }}

*{{cite journal | vauthors=Stewart JL, Kolb WP, Sodetz JM |title=Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement |journal=J. Immunol. |volume=139 |issue= 6 |pages= 1960–4 |year= 1987 |pmid= 3624872 |doi= }}

*{{cite journal | vauthors=Buhl AM, Osawa S, Johnson GL |title=Mitogen-activated protein kinase activation requires two signal inputs from the human anaphylatoxin C5a receptor |journal=J. Biol. Chem. |volume=270 |issue= 34 |pages= 19828–32 |year= 1995 |pmid= 7649993 |doi=10.1074/jbc.270.34.19828 |doi-access=free }}

*{{cite journal | vauthors=Babkina IN, Seregin SV, Daniliuk NK |title=[Chemico-enzymatic synthesis, cloning and expression of a gene for an analog of human anaphylatoxin C5a] |journal=Bioorg. Khim. |volume=21 |issue= 5 |pages= 359–64 |year= 1995 |pmid= 7661861 |doi= |display-authors=etal}}

*{{cite journal | vauthors=Wang X, Fleischer DT, Whitehead WT |title=Inherited human complement C5 deficiency. Nonsense mutations in exons 1 (Gln1 to Stop) and 36 (Arg1458 to Stop) and compound heterozygosity in three African-American families |journal=J. Immunol. |volume=154 |issue= 10 |pages= 5464–71 |year= 1995 |pmid= 7730648 |doi= |display-authors=etal}}

Line 48:

*{{cite journal | vauthors=Arribas J, Arizti P, Castaño JG |title=Antibodies against the C2 COOH-terminal region discriminate the active and latent forms of the multicatalytic proteinase complex |journal=J. Biol. Chem. |volume=269 |issue= 17 |pages= 12858–64 |year= 1994 |pmid= 8175701 |doi= }}

*{{cite journal | vauthors=Süsal C, Kirschfink M, Kröpelin M |title=Identification of complement activation sites in human immunodeficiency virus type-1 glycoprotein gp120 |journal=Blood |volume=87 |issue= 6 |pages= 2329–36 |year= 1996 |pmid= 8630395 |doi= |display-authors=etal}}

*{{cite journal | vauthors=Ames RS, Li Y, Sarau HM |title=Molecular cloning and characterization of the human anaphylatoxin C3a receptor |journal=J. Biol. Chem. |volume=271 |issue= 34 |pages= 20231–4 |year= 1996 |pmid= 8702752 |doi=10.1074/jbc.271.34.20231 |display-authors=etal|doi-access=free }}

*{{cite journal | vauthors=Fredslund F, Laursen NS, Roversi P | title=Structure of and influence of a tick complement inhibitor on human complement component 5 | journal=Nat Immunol |volume= 9 |issue= 7 |pages= 753–60 |year= 2008 |pmid= 18536718 | doi=10.1038/ni.1625 |display-authors=etal}}

{{refend}}